Intrinsic Value
KalVista Pharmaceuticals, Inc. (KALV)
$10.465
-0.03 (-0.24%)
| Enterprise Value | -225.61 |
|---|---|
| Net Debt | -48.01 |
| Equity Value | -177.60 |
| Shares Outstanding | 27.89 |
| Equity Value Per Share | -6.37 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt